ITGAM and neoplasm: Furthermore, like DCs, CD11b+Gr-1+ cells that are immunostimulatory can efficiently cross-prime cytotoxic T lymphocytes and suppress tumor progression in a subcutaneous injection tumor-bearing mouse model through adoptive transfer91.